Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

Cost of Revenue

$1.99B

Quarterly · Period ending: Jun 30, 2026 · USD

TEVA Cost of Revenue

Latest reported$1.99Bperiod endingJun 30, 2026

Latest reported$1.99Bperiod endingJun 30, 2026

TEVA Quarterly Cost of Revenue ($0.00 → $1.99B)

Quarterly cost of revenue

High-resolution chart · PNG

TEVA cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	308,845,000
Mar 31, 2001	293,965,000
Dec 31, 2000	217,797,000
Sep 30, 2000	269,721,000
Jun 30, 2000	251,101,000
Mar 31, 2000	199,751,000
Dec 31, 1999	158,803,000
Sep 30, 1999	192,700,000
Jun 30, 1999	172,900,000
Mar 31, 1999	174,800,000
Dec 31, 1998	121,300,000
Sep 30, 1998	186,000,000
Jun 30, 1998	158,400,000
Mar 31, 1998	170,500,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Sep 30, 1987	0
Jun 30, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0
Mar 31, 1986	0
Dec 31, 1985	0
Sep 30, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.